Frontlight ResearchEarly access
Pancreatic cancer trials in China
326 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleEfficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer
- Where
- Jinan
- Age
- 18 years to 70 years
- People
- 24
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT07600268 - Phase 3Taking peopleAn Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
- Where
- Shanghai, Tianjin
- Age
- 18 years to 75 years
- People
- 220
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT05884255 - Phase 1Taking peopleTo Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
- Where
- Beijing
- Age
- 18 years to 70 years
- People
- 48
- Run by
- Shenzhen Xinhe Biomedical
See details and how to joinNCT07594964 - Phase 1/2Taking peopleNALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 55
- Run by
- West China Hospital
See details and how to joinNCT07595172 - Early phase 1Taking peoplePreliminary Trial of SNA014 for Pancreatic Cancer
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 12
- Run by
- SmartNuclide Biopharma
See details and how to joinNCT07597772 - Phase 1Not yet taking people in ChinaA Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 18
- Run by
- Beijing DCTY Biotech Co.,Ltd.
See details and how to joinNCT07014878 - Phase 1/2Taking peopleA Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer
- Where
- Shenzhen
- Age
- 18 years to 80 years
- People
- 23
- Run by
- Junjie Hang
See details and how to joinNCT07040228 - Phase 3Not yet taking people in ChinaA Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 231
- Run by
- Lepu Biopharma Co., Ltd.
See details and how to joinNCT07138846 - No phaseTaking people18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- Where
- Beijing
- Age
- 18 years and over
- People
- 200
- Run by
- Peking University First Hospital
See details and how to joinNCT07557225 - Phase 2Taking peopleRomiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
- Where
- Beijing
- Age
- 18 years and over
- People
- 220
- Run by
- Peking University People's Hospital
See details and how to joinNCT07586813 - Phase 1Not yet taking people in ChinaA Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma
- Where
- Shanghai
- Age
- 18 years and over
- People
- 186
- Run by
- Chipscreen Biosciences, Ltd.
See details and how to joinNCT07583771 - Phase 1/2Taking peopleAdapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 37
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT06844422 - Phase 1Not yet taking people in ChinaChimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer Patients
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 18
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07553793 - No phaseNot yet taking people in ChinaNon-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET Imaging
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 64
- Run by
- Ruijin Hospital
See details and how to joinNCT07554742 - No phaseTaking peopleSub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
- Where
- Wuhan
- Age
- 18 years and over
- People
- 26
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07552467 - Phase 1/2Taking peopleA Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Linyi, Nanchang, Shanghai, Taizhou, Wuhan
- Age
- 18 years to 75 years
- People
- 440 worldwide
- Run by
- Tyligand Pharmaceuticals (Suzhou) Limited
See details and how to joinNCT06385925 - Phase 2Taking peopleLiposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors:A Prospective Exploratory Study
- Where
- Ningbo
- Age
- 18 years to 75 years
- People
- 37
- Run by
- Ningbo Medical Center Lihuili Hospital
See details and how to joinNCT07542002 - Phase 2Taking peopleAuricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel
- Where
- Hangzhou
- Age
- 18 years to 85 years
- People
- 25
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07537660 - Phase 1/2Taking peopleStudy of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
- Where
- Baoding, Beijing, Binzhou, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Kunming, Linyi, Luoyang, Shanghai, Wuhan, Yunnan
- Age
- 18 years and over
- People
- 350
- Run by
- Evopoint Biosciences Inc.
See details and how to joinNCT06799637 - Phase 1/2Taking peopleKRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 49
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07353645 - Phase 1/2Taking peopleBiomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
- Where
- Shenzhen
- Age
- 18 years to 75 years
- People
- 72
- Run by
- Beijing Biotech
See details and how to joinNCT07523529 - No phaseTaking peopleTreatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
- Where
- Shanghai
- Age
- 18 years and over
- People
- 21
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06141369 - Phase 2Taking peopleHepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases
- Where
- Shanghai
- Age
- 18 years and over
- People
- 50
- Run by
- Ruijin Hospital
See details and how to joinNCT07504471 - No phaseTaking peoplePlasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
- Where
- Chengdu, Shanghai
- Age
- 18 years and over
- People
- 1,000
- Run by
- Fudan University
See details and how to joinNCT05847855 - No phaseNot yet taking people in ChinaTo Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.
- Where
- Shanghai
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- Unidade Local de Saúde São João, Oporto
See details and how to joinNCT07493421